C Dahle
Overview
Explore the profile of C Dahle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmad A, Heijke R, Eriksson P, Wirestam L, Kechagias S, Dahle C, et al.
Clin Exp Immunol
. 2020 Sep;
203(1):22-31.
PMID: 32910463
Knowledge of concomitant autoimmune liver diseases (AILD) is more detailed in primary Sjögren's syndrome (pSS) compared to systemic lupus erythematosus (SLE). Herein, the prevalence of autoantibodies associated with autoimmune hepatitis...
2.
Frodlund M, Wettero J, Dahle C, Dahlstrom O, Skogh T, Ronnelid J, et al.
Clin Exp Immunol
. 2019 Nov;
199(3):245-254.
PMID: 31778219
Serum immunoglobulin (Ig)G anti-nuclear antibodies (ANA) detected by indirect immunofluorescence (IF) microscopy remains a hallmark of systemic lupus erythematosus (SLE). Whether or not IF-ANA status varies over time is controversial....
3.
Hakansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, et al.
Eur J Neurol
. 2017 Mar;
24(5):703-712.
PMID: 28261960
Background And Purpose: Improved biomarkers are needed to facilitate clinical decision-making and as surrogate endpoints in clinical trials in multiple sclerosis (MS). We assessed whether neurodegenerative and neuroinflammatory markers in...
4.
Mellergard J, Tisell A, Blystad I, Gronqvist A, Blennow K, Olsson B, et al.
Eur J Neurol
. 2016 Oct;
24(1):112-121.
PMID: 27699930
Background And Purpose: Brain atrophy is related to clinical deterioration in multiple sclerosis (MS) but its association with intrathecal markers of inflammation or neurodegeneration is unclear. Our aim was to...
5.
Lewander P, Dahle C, Larsson B, Wettero J, Skogh T
Scand J Rheumatol
. 2016 Jul;
46(3):194-197.
PMID: 27385219
Objectives: Raised serum cartilage oligomeric matrix protein (sCOMP) has been reported to predict erosive disease in early rheumatoid arthritis (RA). In juvenile idiopathic arthritis (JIA), subnormal sCOMP levels have been...
6.
Dahle C, Vrethem M, Olsson J, Ernerudh J
Eur J Neurol
. 2013 Nov;
2(4):331-6.
PMID: 24283684
Anticardiolipin antibodies (ACA) were analysed in 502 consecutive patients admitted to our stroke unit Elevated ACA levels ≥11 units) were found in 20 of 396 patients (5%) with ischemic stroke...
7.
Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, et al.
Mult Scler
. 2012 Nov;
19(6):765-74.
PMID: 23124789
Background: It is currently unknown whether early immunomodulatory treatment in relapsing-remitting MS (RRMS) can delay the transition to secondary progression (SP). Objective: To compare the time interval from onset to...
8.
Vrethem M, Lindh J, Tondel M, Persson B, Dahle C
Acta Neurol Scand
. 2012 Jun;
127(2):109-15.
PMID: 22651850
Objectives: To study the prevalence of antibodies of IgA class against tissue transglutaminase (tTG), endomysium (EMA) and gliadin (AGA) in patients with chronic idiopathic axonal polyneuropathy (CIAP) and to characterize...
9.
Edstrom M, Mellergard J, Mjosberg J, Jenmalm M, Vrethem M, Press R, et al.
Mult Scler
. 2010 Sep;
17(1):57-66.
PMID: 20847001
Background: Multiple sclerosis (MS) is hypothetically caused by autoreactive Th1 and Th17 cells, whereas Th2 and regulatory T cells may confer protection. The development of Th subpopulations is dependant on...
10.
Dahle C, Hagman A, Ignatova S, Strom M
Aliment Pharmacol Ther
. 2010 May;
32(2):254-60.
PMID: 20456302
Background: This study was done to evaluate the diagnostic utility of antibodies against deamidated gliadin peptides compared to traditional markers for coeliac disease. Aim: To evaluate diagnostic utility of antibodies...